We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Olympus

Manufactures optical and digital equipment for the healthcare and consumer electronics sectors, including endoscopy a... read more Featured Products: More products

Download Mobile App




Next-Gen Electrosurgical Generator Enhances Efficiencies in Treatment of Bladder Cancer and Enlarged Prostate

By HospiMedica International staff writers
Posted on 07 Jun 2023
Print article
Image: The ESG-410 next generation electrosurgical generator (Photo courtesy of Olympus)
Image: The ESG-410 next generation electrosurgical generator (Photo courtesy of Olympus)

Bladder cancer remains a significant global health issue and the leading contributor to cancer-related deaths worldwide. As the tenth most common cancer globally, it also ranks as the second most prevalent urinary tract malignancy, resulting in around 549,000 new cases and approximately 200,000 deaths each year. Despite its widespread occurrence, advanced bladder cancer treatment options remain scarce. In addition, benign prostatic hyperplasia (BPH), a common issue affecting 50% of men between 51 and 60 and up to 90% of men over 80, further compounds urinary health concerns. Now, a new electrosurgical generator designed for use in the treatment of bladder cancer and enlarged prostate aims to improve patient outcomes by elevating the standard of care.

The new ESG-410 electrosurgical generator from Olympus (Center Valley, PA, USA) is designed to facilitate and streamline the treatment of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia (BPH), or enlarged prostate. This device comes equipped with a range of resection loops, band electrodes, and vaporization buttons and needles. The ESG-410 electrosurgical generator and its accompanying accessories and ancillary equipment are intended for tissue cutting and coagulation in open, laparoscopic, and endoscopic surgeries. Compared to its predecessor, the ESG-400, the ESG-410 includes larger capacitors for improved plasma stability during ignition.

The ESG-410 generator requires less energy for ignition than its predecessor and enhances procedural efficiency in BPH resections due to its ability to reliably ignite larger resection loops, thereby accelerating tissue removal. The ESG-410 also outperforms the ESG-400 by offering quicker ignition and improved plasma stability, even without tissue contact, with large, medium, and band loops and oval buttons. It also features a larger 8.4" LCD touch screen and includes wireless foot pedals, providing a significant upgrade from the ESG-400.

Related Links:
Olympus

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Bronchoscope
EB-500

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.